TR201905974T4 - İmmünoglobuli̇nleri̇n hazirlanmasi i̇çi̇n yöntem - Google Patents

İmmünoglobuli̇nleri̇n hazirlanmasi i̇çi̇n yöntem Download PDF

Info

Publication number
TR201905974T4
TR201905974T4 TR2019/05974T TR201905974T TR201905974T4 TR 201905974 T4 TR201905974 T4 TR 201905974T4 TR 2019/05974 T TR2019/05974 T TR 2019/05974T TR 201905974 T TR201905974 T TR 201905974T TR 201905974 T4 TR201905974 T4 TR 201905974T4
Authority
TR
Turkey
Prior art keywords
solution
solution obtained
immunoglobulin
preparing
starting
Prior art date
Application number
TR2019/05974T
Other languages
English (en)
Inventor
Ristol Debart Pere
Grancha Gamon Salvador
Ignacio Jorquera Nieto Juan
Mercedes Faro Tomas Maria
Jorba Grifols Nuria
Original Assignee
Inst Grifols S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Grifols S A filed Critical Inst Grifols S A
Publication of TR201905974T4 publication Critical patent/TR201905974T4/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39516—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum from serum, plasma
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24361—Methods of inactivation or attenuation
    • C12N2770/24363—Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Analytical Chemistry (AREA)
  • Water Supply & Treatment (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Mevcut buluş, bir polieter veya glikol polimerinin varlığında %96'dan büyük veya ona eşit bir saflığa sahip bir immünoglobulin başlangıç çözeltisine dayanan bir immünoglobulin çözeltisinin hazırlanması için bir yöntemle ilgili olup ayırt edici özelliği şu adımları ihtiva etmesidir: a) başlangıç çözeltisine kaprilik asit veya bunun tuzlarının eklenmesi; b) a) adımında elde edilen çözeltinin pH'ının ayarlanması; c) b) adımında elde edilen çözeltinin zarflı virüslerin inaktivasyonu için gerekli süre kadar ve sıcaklıkta inkübe edilmesi; d) c) adımında elde edilen çözelti üzerinde ultrafiltrasyon/diyafiltrasyon adımının gerçekleştirilmesi.
TR2019/05974T 2015-08-31 2016-03-10 İmmünoglobuli̇nleri̇n hazirlanmasi i̇çi̇n yöntem TR201905974T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES201531243 2015-08-31

Publications (1)

Publication Number Publication Date
TR201905974T4 true TR201905974T4 (tr) 2019-05-21

Family

ID=55646274

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/05974T TR201905974T4 (tr) 2015-08-31 2016-03-10 İmmünoglobuli̇nleri̇n hazirlanmasi i̇çi̇n yöntem

Country Status (8)

Country Link
US (1) US10358462B2 (tr)
EP (1) EP3135687B1 (tr)
ES (1) ES2721311T3 (tr)
HU (1) HUE042984T2 (tr)
MY (1) MY181270A (tr)
PL (1) PL3135687T3 (tr)
PT (1) PT3135687T (tr)
TR (1) TR201905974T4 (tr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3638693A4 (en) 2017-06-12 2021-04-14 Kamada Ltd IMMUNOGLOBULIN COMPOSITIONS AND PROCESS FOR THEIR PREPARATION
RU2728724C2 (ru) * 2018-09-13 2020-07-30 Акционерное общество "Научно-производственное объединение по медицинским иммунобиологическим препаратам "Микроген" Способ получения вирусбезопасного раствора иммуноглобулина g человека для внутримышечного введения
WO2021244910A1 (en) * 2020-06-03 2021-12-09 Grifols Worldwide Operations Limited Hyperimmune igg and/or igm compositions and method for preparing thereof and method for obtaining hyperimmune human plasma from a donor

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4164495A (en) * 1976-04-06 1979-08-14 Nordisk Insulinlaboratorium Method of recovering immunoglobulin using a polyol and an alkanoic acid
JPS5874617A (ja) 1981-10-28 1983-05-06 Green Cross Corp:The 人由来血液凝固第７因子含有水溶液の加熱処理方法
DE3641115A1 (de) * 1986-12-02 1988-06-16 Lentia Gmbh Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins
US5886154A (en) 1997-06-20 1999-03-23 Lebing; Wytold R. Chromatographic method for high yield purification and viral inactivation of antibodies
US6281336B1 (en) * 1998-06-09 2001-08-28 Statens Serum Institut Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
ES2184594B1 (es) 2001-01-17 2004-01-01 Probitas Pharma Sa Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
JP2008500959A (ja) 2004-01-30 2008-01-17 スオメン プナイネン リスティ ヴェリパルヴェル ウイルスについて安全な免疫グロブリンの製造方法
EP1718675B2 (en) 2004-02-27 2017-01-25 Octapharma AG A method of providing a purified, virus safe antibody preparation
ES2381828B1 (es) * 2012-03-20 2012-11-16 Grifols, S.A. PROCEDIMIENTO PARA OBTENER UNA COMPOSICION DE IgG MEDIANTE TRATAMIENTO TERMICO
US10508133B2 (en) * 2013-10-18 2019-12-17 Novasep Process Purification of proteins
US10738078B2 (en) * 2014-11-03 2020-08-11 Bristol-Myers Squibb Company Use of caprylic acid precipitation for protein purification

Also Published As

Publication number Publication date
PT3135687T (pt) 2019-05-21
MY181270A (en) 2020-12-21
HUE042984T2 (hu) 2019-07-29
EP3135687B1 (en) 2019-04-10
ES2721311T3 (es) 2019-07-30
EP3135687A1 (en) 2017-03-01
US20170198009A1 (en) 2017-07-13
PL3135687T3 (pl) 2019-09-30
US10358462B2 (en) 2019-07-23

Similar Documents

Publication Publication Date Title
CY1124921T1 (el) Μεθοδοι για την εκχυλιση και τον καθαρισμο μη μετουσιωμενων πρωτεϊνων
PH12018500856A1 (en) Respiratory syncytial virus vaccine
MX2023001189A (es) Produccion de acido ribonucleico libre de celulas.
BR112018010341A2 (pt) composição, sistema e método para tratamento do cabelo, método para alteração da cor do cabelo, e, kit de multicompartimentos para alteração da cor ou do formato do cabelo.
BR112015031509A2 (pt) Polipeptídeo, molécula de ácido nucleico, vetor, e, composição
BR112017023719A2 (pt) planta de tabaco, parte de planta e/ou célula de planta, semente, cultura de planta, produto de tabaco, método para reduzir pon e/ou nnk, método de produção de uma planta e método para produzir um produto de tabaco
MX2022015257A (es) Proteinas f de prefusion del virus respiratorio sincicial (vrs) solubles y estabilizadas.
BR112016023854A2 (pt) silano contendo grupo amidina ou grupo guanidina
CY1122850T1 (el) Υπερδιακλαδισμενος πολυ (βητα-αμινοεστερας) για γονιδιακη θεραπεια
EA201691794A1 (ru) Конденсированные [1,4]диазепиновые соединения в качестве ингибиторов продукции аутотаксина (atx) и лизофосфатидиловой кислоты (lpa)
CY1123840T1 (el) Οξινη συνθεση με βαση λεοναρδιτη και αμινοξεα
TR201905974T4 (tr) İmmünoglobuli̇nleri̇n hazirlanmasi i̇çi̇n yöntem
BR112015004467A2 (pt) método para controlar a heterogeneidade de proteínas
MX2018003298A (es) Metodo para preparar una formulacion de proteinas terapeuticas y formulacion de anticuerpos producida por tal metodo.
EA201992232A1 (ru) Композиции и способы для иммуноонкологии
AR105082A1 (es) Sistema y método de producción de un concentrado de sílice
WO2018067582A3 (en) Hiv-1 env fusion peptide immunogens and their use
PH12017502386A1 (en) Methods of purification and/or viral inactivation
BR112021012496A2 (pt) Enterovírus adaptado bem como seu método e processo de adaptação, sequências de nucleotídeo e aminoácido, método para inativar enterovírus e composição imunogênica
BR112017016194A2 (pt) método
EA201990735A1 (ru) 6-членные циклические амины или лактамы, замещенные мочевиной и фенилом
UA114997C2 (uk) Рекомбінантний мікроорганізм з роду escherichia, що виробляє l-амінокислоту, та спосіб одержання l-амінокислоти
MX2016012506A (es) Procedimiento de preparacion de inmunoglobulinas.
MX2018001687A (es) Metodos y sistemas para extraer proteina de acido oxalico reducido de especies acuaticas y composiciones de la misma.
AR106140A1 (es) Procedimiento de preparación de inmunoglobulinas